Viewing StudyNCT02269813



Ignite Creation Date: 2024-05-06 @ 3:19 AM
Last Modification Date: 2024-10-26 @ 11:32 AM
Study NCT ID: NCT02269813
Status: COMPLETED
Last Update Posted: 2019-08-13
First Post: 2014-10-14

Brief Title: PRospective Study to Measure the Impact of MammaPrint on Adjuvant Treatment in Hormone Receptor-positive HER2-negative Breast Cancer Patients PRIMe
Sponsor:
Organization: West German Study Group

Study Design

Study Type: OBSERVATIONAL
Expanded Access Type Individual: None
Expanded Access Type Intermediate: None
Expanded Access Type Treatment: None
Patient Registry: False
Target Duration: None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention: None
Bio Spec Description: None
Enrollment Count: 452
Enrollment Type: ACTUAL
Design Primary Purpose:
Design Masking:
Phases:
Observational Models:
Name
Case-Control
Time Perspective List:

Clinical Trial Statuses

Name
27444
Who Masked List: